These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31678838)

  • 1. Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials.
    Oon-Arom A; Likhitsathain S; Srisurapanont M
    Drug Alcohol Depend; 2019 Dec; 205():107631. PubMed ID: 31678838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Varenicline on Alcohol Consumption in Subjects With Alcohol Use Disorders: Systematic Review and Meta-Analyses.
    Gandhi KD; Mansukhani MP; Karpyak VM; Schneekloth TD; Wang Z; Kolla BP
    J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32097546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Varenicline in the Treatment of Alcohol Dependence: An Updated Meta-Analysis and Meta-Regression.
    Phimarn W; Sakhancord R; Paitoon P; Saramunee K; Sungthong B
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial.
    de Bejczy A; Löf E; Walther L; Guterstam J; Hammarberg A; Asanovska G; Franck J; Isaksson A; Söderpalm B
    Alcohol Clin Exp Res; 2015 Nov; 39(11):2189-99. PubMed ID: 26414337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Varenicline in Patients With Severe Alcohol Dependence: A Pilot Double-Blind Randomized and Controlled Study.
    Pfeifer P; Fehr C
    J Clin Psychopharmacol; 2019; 39(4):398-402. PubMed ID: 31188242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline in the treatment of alcohol use disorders.
    Erwin BL; Slaton RM
    Ann Pharmacother; 2014 Nov; 48(11):1445-55. PubMed ID: 25095786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled, multicentre trial on the efficacy of varenicline and bupropion in combination and alone for treatment of alcohol use disorder: Protocol for the COMB study.
    de Bejczy A; Lidö H; Söderpalm B
    PLoS One; 2024; 19(1):e0296118. PubMed ID: 38206930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
    Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
    Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
    Palpacuer C; Laviolle B; Boussageon R; Reymann JM; Bellissant E; Naudet F
    PLoS Med; 2015 Dec; 12(12):e1001924. PubMed ID: 26694529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
    Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
    JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.
    O'Malley SS; Zweben A; Fucito LM; Wu R; Piepmeier ME; Ockert DM; Bold KW; Petrakis I; Muvvala S; Jatlow P; Gueorguieva R
    JAMA Psychiatry; 2018 Feb; 75(2):129-138. PubMed ID: 29261824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid antagonists for alcohol dependence.
    Srisurapanont M; Jarusuraisin N
    Cochrane Database Syst Rev; 2005 Jan; (1):CD001867. PubMed ID: 15674887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics for primary alcohol dependence: a systematic review and meta-analysis of placebo-controlled trials.
    Kishi T; Sevy S; Chekuri R; Correll CU
    J Clin Psychiatry; 2013 Jul; 74(7):e642-54. PubMed ID: 23945459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of varenicline on cognitive performance in heavy drinkers: Dose-response effects and associations with drinking outcomes.
    Roberts W; McKee SA
    Exp Clin Psychopharmacol; 2018 Feb; 26(1):49-57. PubMed ID: 29389170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.
    Nieto SJ; Enders CK; Witkiewitz K; O'Malley SS; Ray LA
    Alcohol Clin Exp Res; 2022 Dec; 46(12):2258-2266. PubMed ID: 36515648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of varenicline on alcohol cue reactivity in heavy drinkers.
    Roberts W; Harrison ELR; McKee SA
    Psychopharmacology (Berl); 2017 Sep; 234(18):2737-2745. PubMed ID: 28600734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers.
    Vatsalya V; Gowin JL; Schwandt ML; Momenan R; Coe MA; Cooke ME; Hommer DW; Bartlett S; Heilig M; Ramchandani VA
    Int J Neuropsychopharmacol; 2015 Jul; 18(12):. PubMed ID: 26209857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.